Human Phospholipase A2, Cytosolic (cPLA2) Protein

REQUEST MORE INFO
Catalogue No: abx068535
Price: US$261.00
(Size: 10 µg)

Click on the image to see the image legend

Available Options

* Size:






Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Recombinant Phospholipase A2, Cytosolic (cPLA2) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Target Phospholipase A2, Cytosolic (cPLA2)
Origin Human
Expression Recombinant
Tested Applications WB, SDS-PAGE
Host E. coli
Conjugation Unconjugated
Form Lyophilized
Purity > 95%
Reconstitution To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Storage Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
UniProt Primary AC P47712 (UniProt, ExPASy)
UniProt Secondary AC B1AKG4, Q29R80
UniProt Entry Name PA24A_HUMAN
KEGG hsa:5321
String 9606.ENSP00000356436
Molecular Weight Calculated MW: 23.5 kDa
Sequence Fragment Arg563-Ala749
Sequence RPQRGVDL IISFDFSARP SDSSPPFKEL LLAEKWAKMN KLPFPKIDPY VFDREGLKEC YVFKPKNPDM EKDCPTIIHF VLANINFRKY RAPGVPRETE EEKEIADFDI FDDPESPFST FNFQYPNQAF KRLHDLMHFN TLNNIDVIKE AMVESIEYRR QNPSRCSVSL SNVEARRFFN KEFLSKPKA
Tag N-terminal His tag
Buffer Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Activity Not tested
Concentration Prior to lyophilization: 200 µg/ml
Availability Shipped within 5-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Phospholipase A2, Cytosolic (cPLA2)


Write a review